Claudia Carrieri

Claudia Carrieri

Auto-generated profile, based on publicly available information

Claudia Carrieri

MRC Centre for Regenerative Medicine, Institute for Stem Cell Research, School of Biological Sciences, University of Edinburgh, Edinburgh, UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2012 in Nature
Verified
Journal Article
Closed access
CCClaudia Carrieri
Claudia Carrieri
LCLaura Cimatti
Laura Cimatti
MBMarta Biagioli
Marta Biagioli
ABAnne Beugnet
Anne Beugnet
SZSilvia Zucchelli
Silvia Zucchelli
SGStefano Gustincich
Stefano Gustincich

1 September 2017 in Molecular Cell
Verified
Journal Article
Open access
IIIvayla Ivanova
Ivayla Ivanova
CMChristian Much
Christian Much
MGMonica Di Giacomo
Monica Di Giacomo
CAChiara Azzi
Chiara Azzi
MMMarcos Morgan
Marcos Morgan
DODónal O’cArroll
Dónal O’cArroll
YTHDF2 binds and destabilizes N6-methyladenosine (m6A)-modified mRNA. The extent to which this branch of m6A RNA-regulatory pathway functions in vivo and contributes to mammalian development remains unknown. Here we find that YTHDF2 deficiency is partially permissive in mice and results in female-specific infertility. Using conditional mutagenesis, we demonstrate that YTHDF2 is autonomously required within the germline to produce MII oocytes that are competent to sustain early zygotic development. Oocyte maturation is associated with a wave of maternal RNA degradation, and the resulting relative changes to the MII transcriptome are integral to oocyte quality. The loss of YTHDF2 results in the failure to regulate transcript dosage of a cohort of genes during oocyte maturation, with enrichment observed for the YTHDF2-binding consensus and evidence of m6A in these upregulated genes. In summary, the m6A-reader YTHDF2 is an intrinsic determinant of mammalian oocyte competence and early zygotic development.

1 May 2013 in Molecular Cell
Verified
Journal Article
Closed access
MGMonica Di Giacomo
Monica Di Giacomo
SCStefano Comazzetto
Stefano Comazzetto
HSHarpreet Saini
Harpreet Saini
SFSerena De Fazio
Serena De Fazio
CCClaudia Carrieri
Claudia Carrieri
DODónal O’carroll
Dónal O’carroll

26 February 2018 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
ABAngelo Bitetti
Angelo Bitetti
AMAllison C. Mallory
Allison C. Mallory
EGElisabetta Golini
Elisabetta Golini
CCClaudia Carrieri
Claudia Carrieri
HGHéctor Carreño Gutiérrez
Héctor Carreño Gutiérrez
ASAlena Shkumatava
Alena Shkumatava
MicroRNAs (miRNAs) repress target transcripts through partial complementarity. By contrast, highly complementary miRNA-binding sites within viral and artificially engineered transcripts induce miRNA degradation in vitro and in cell lines. Here, we show that a genome-encoded transcript harboring a near-perfect and deeply conserved miRNA-binding site for miR-29 controls zebrafish and mouse behavior. This transcript originated in basal vertebrates as a long noncoding RNA (lncRNA) and evolved to the protein-coding gene NREP in mammals, where the miR-29-binding site is located within the 3′ UTR. We show that the near-perfect miRNA site selectively triggers miR-29b destabilization through 3′ trimming and restricts its spatial expression in the cerebellum. Genetic disruption of the miR-29 site within mouse Nrep results in ectopic expression of cerebellar miR-29b and impaired coordination and motor learning. Thus, we demonstrate an endogenous target-RNA-directed miRNA degradation event and its requirement for animal behavior.

22 December 2011 in Genome Research
Verified
Journal Article
Open access
PDF file
CPCharles Plessy
Charles Plessy
GPGiovanni Pascarella
Giovanni Pascarella
NBNicolas Bertin
Nicolas Bertin
AAAltuna Akalin
Altuna Akalin
CCClaudia Carrieri
Claudia Carrieri
Piero CarninciPiero Carninci
Piero Carninci
Odorous chemicals are detected by the mouse main olfactory epithelium (MOE) by about 1100 types of olfactory receptors (OR) expressed by olfactory sensory neurons (OSNs). Each mature OSN is thought to express only one allele of a single OR gene. Major impediments to understand the transcriptional control of OR gene expression are the lack of a proper characterization of OR transcription start sites (TSSs) and promoters, and of regulatory transcripts at OR loci. We have applied the nanoCAGE technology to profile the transcriptome and the active promoters in the MOE. nanoCAGE analysis revealed the map and architecture of promoters for 87.5% of the mouse OR genes, as well as the expression of many novel noncoding RNAs including antisense transcripts. We identified candidate transcription factors for OR gene expression and among them confirmed by chromatin immunoprecipitation the binding of TBP, EBF1 (OLF1), and MEF2A to OR promoters. Finally, we showed that a short genomic fragment flanking the major TSS of the OR geneOlfr160(M72) can drive OSN-specific expression in transgenic mice.

1 April 2015 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
CCClaudia Carrieri
Claudia Carrieri
AFAlistair R. R. Forrest
Alistair R. R. Forrest
CSClaudio Santoro
Claudio Santoro
FPFrancesca Persichetti
Francesca Persichetti
Piero CarninciPiero Carninci
Piero Carninci
SGStefano Gustincich
Stefano Gustincich
Antisense (AS) transcripts are RNA molecules that are transcribed from the opposite strand to sense (S) genes forming S/AS pairs. The most prominent configuration is when a lncRNA is antisense to a protein coding gene. Increasing evidences prove that antisense transcription may control sense gene expression acting at distinct regulatory levels. However, its contribution to brain function and neurodegenerative diseases remains unclear. We have recently identified AS Uchl1 as an antisense to the mouse Ubiquitin carboxy-terminal hydrolase L1 (Uchl1) gene (AS Uchl1), the synthenic locus of UCHL1/PARK5. This is mutated in rare cases of early-onset familial Parkinson’s Disease (PD) and loss of UCHL1 activity has been reported in many neurodegenerative diseases. Importantly, manipulation of UchL1 expression has been proposed as tool for therapeutic intervention. AS Uchl1 induces UchL1 expression by increasing its translation. It is the representative member of SINEUPs (SINEB2 sequence to UP-regulate translation), a new functional class of natural antisense lncRNAs that activate translation of their sense genes. Here we take advantage of FANTOM5 dataset to identify the transcription start sites associated to S/AS pair at Uchl1 locus. We show that AS Uchl1 expression is under the regulation of Nurr1, a major transcription factor involved in dopaminergic cells’ differentiation and maintenance. Furthermore, AS Uch1 RNA levels are strongly down-regulated in neurochemical models of PD in vitro and in vivo. This work positions AS Uchl1 RNA as a component of Nurr1-dependent gene network and target of cellular stress extending our understanding on the role of antisense transcription in the brain.